Latest Johnson & Johnson News & Updates
See the latest news and media coverage for J&J. We track all announcements, press releases, and industry mentions in real time, all in one place.
Multinational healthcare company
jnj.com- Headquarters
- New Brunswick, United States
- Company type
- Public company
- Number of employees
- 100,000+
Last updated
Latest news about Johnson & Johnson (J&J)
In short: J&J reported strong Q1 2026 sales of $24.1 billion, raised its full-year guidance, and faced legal developments regarding its talcum powder cases.
Company announcements
-
J&J announces JNJ-4804 Phase 2b data
JNJ-4804 shows superior clinical remission and endoscopic response in refractory UC and CD patients vs comparators. Supports Phase 3 advancement.
-
J&J announces TREMFYA efficacy in perianal fistulizing Crohn’s
Phase 3 FUZION study shows 27-28% combined fistula remission at Week 24 vs 10% placebo. First such trial in 20 years, presented at DDW 2026.
-
J&J announces pivotal clinical study results
Data show OTTAVA met primary safety and performance endpoints in a 30‑patient Roux‑en‑Y study. Findings supported a De Novo FDA application.
-
J&J announces CAPLYTA shows greatest efficacy in MDD meta-analysis
CAPLYTA ranked highest across four efficacy measures and showed no weight gain versus placebo plus ADT in network meta-analysis presented at NEI Congress.
Media coverage
-
J&J Feared FDA's 'Disturbing Proposal' To Test Talc, Jury Told - Law360
A former U.S. Food and Drug Administration commissioner testifying Thursday in a Los Angeles bellwether trial over claims Johnson & Johnson's talc products caused three...
-
Darzalex, Erleada & New Drugs Keep J&J s Oncology Engine Charged in Q1
Johnson & Johnson JNJ is one of the key pharmaceutical players in the oncology segment with...
-
J&J's Ottava surgical robot meets primary endpoints in gastric bypass study
Johnson & Johnson MedTech is touting positive results from the first clinical study of its Ottava soft-tissue surgical robot, showing the system can safely perform...
-
Johnson & Johnson reaches a milestone for one of its most exciting pipeline products
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Track J&J and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore